Levi & Korsinsky, LLP announces that an APYX class action lawsuit has been filed on behalf of investors who purchased Apyx Medical Corporation  (APYX) securities between May 12, 2021, and March 11, 2022. For more on the APYX Lawsuit please contact us today.

According to the Apyx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx’s Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company’s financial results would be adversely impacted; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE APYX CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Apyx you have until August 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com